Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Melanoma × Endoscopy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 4 Rectal Neoplasms 3 Esophageal Neoplasms 3 Colorectal Neoplasms 2 Barrett Esophagus 2 Urogenital Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Pathologic Complete Response 1 Paranasal Sinus Neoplasms 1 Ovarian Neoplasms 1 Nasopharyngeal Neoplasms 1 Melanoma 1 Lung Neoplasms 1 Locally Advanced Pancreatic Cancer 1 Jaw Cysts 1 Gastrointestinal Neoplasms 1 Colitis 1 Carcinoma, Non-Small-Cell Lung 1 Bacteremia 1

Interventions

pembrolizumab 54 Nivolumab 52 Ipilimumab 29 Cyclophosphamide 15 binimetinib 10 Specimen Handling 10 Magnetic Resonance Spectroscopy 10 fludarabine 9 Radiosurgery 9 Opdualag 9 encorafenib 8 Interleukin-2 8 Biopsy 8 relatlimab 7 aldesleukin 7 Blood Specimen Collection 7 atezolizumab 6 Immunotherapy 6 cemiplimab 5 Paclitaxel 5 CTLA-4 Antigen 5 Bevacizumab 5 trametinib 4 lifileucel 4 dabrafenib 4 Temozolomide 4 spartalizumab 3 fludarabine phosphate 3 Surgical Procedures, Operative 3 Standard of Care 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04879654 2024-03-05

SNMM

Eye & ENT Hospital of Fudan University

Phase 2 Recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡